GHK-Cu (Copper Peptide)
GHK-Cu is a naturally occurring copper tripeptide with one of the longest and best-documented track records in this category for topical skin use — but that solid cosmetic reputation is often groundlessly extended to injectable, systemic use, for which human evidence is practically nonexistent.
Number of studies
3
Safety
Requires caution
Time to effects
Topical form: visible changes in skin density and elasticity usually after 8–12 weeks of regular use, matching the duration of clinical trials. Injectable form: time to effect has not been established in human clinical trials.
Monthly cost
ok. 80–250 zł/miesiąc (forma kosmetyczna)
Price in Poland
Forma kosmetyczna: 80–250 zł za opakowanie kremu/serum starczające na 1–2 miesiące. Forma iniekcyjna (gray market): 150–350 zł za fiolkę.
Who it's for
Cena formy iniekcyjnej nie jest wskaźnikiem jakości czy bezpieczeństwa — ten segment rynku jest całkowicie nieregulowany.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
GHK-Cu is a naturally occurring copper tripeptide with one of the longest and best-documented track records in this category for topical skin use — but that solid cosmetic reputation is often groundlessly extended to injectable, systemic use, for which human evidence is practically nonexistent.
- →In controlled clinical trials, topical GHK-Cu increased collagen production and improved skin density and elasticity after 12 weeks of use
- →A randomized, placebo-controlled clinical trial in patients with diabetic foot ulcers showed significantly faster and more complete wound closure with GHK-Cu gel than with standard care
- →In vitro studies on dermal fibroblasts show increased collagen and elastin production even at very low concentrations
| What it is | A naturally occurring tripeptide (Gly-His-Lys) complexed with a Cu2+ copper ion |
|---|---|
| Evidence level — topical form | Moderate — several controlled clinical trials on skin and chronic wounds |
| Evidence level — injectable/systemic form | Very weak — practically only animal and cell-culture studies |
| Main mechanism | MMP/TIMP modulation, lysyl oxidase cofactor, chemotactic and antioxidant action |
| Status | Approved cosmetic ingredient for topical use; injectable form sold in the "research compound" gray market |
| Concentration in the body | Declines with age — from ~200 ng/ml plasma at age 20 to ~80 ng/ml at age 60 |
Understand
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine complexed with a Cu2+ copper ion) is a naturally occurring tripeptide in the human body, first isolated from human plasma in the 1970s by biochemist Loren Pickart. Its plasma concentration consistently declines with age — averaging about 200 ng/ml in twenty-year-olds versus roughly 80 ng/ml in sixty-year-olds — which became the starting point for the hypothesis that supplementing exogenous GHK-Cu might partially restore the regenerative signaling typical of younger skin and tissue.
Among all the peptides covered on this blog in the regenerative-biohacking category, GHK-Cu stands out because part of its use — specifically topical, cosmetic application to the skin — has real, controlled human clinical trials behind it, including randomized comparative studies against active comparators (vitamin C, retinoic acid). That puts GHK-Cu in a fundamentally different evidence category than BPC-157 or TB-500, whose regenerative reputation rests almost entirely on rodent studies.
This relatively solid evidence base, however, applies only to the topical form (creams, serums, impregnated dressings) applied to intact skin or chronic wounds under research supervision. A completely different, far more weakly supported category is injectable or systemic GHK-Cu, promoted in biohacking circles as a method of whole-body regeneration, improved bone density, or supporting healing from the inside — for this route of administration, practically no controlled human clinical trials exist, and available data is limited to mechanistic studies in animals and cell cultures.
Mechanistically, GHK-Cu is one of the better-described regenerative peptides in terms of its effect on gene expression — a 2018 review by Pickart and Margolina, based on Connectivity Map–type analyses, indicates the peptide influences expression of over four thousand human genes, including many linked to collagen synthesis, extracellular matrix metalloproteinases, antioxidant response, and DNA repair processes. This richness of described molecular pathways is sometimes confused in marketing with clinical proof — breadth of transcriptomic influence alone is not the same as a confirmed, measurable clinical benefit in a specific indication for a specific patient group.
In cosmetic practice, GHK-Cu has been a component of professional and consumer anti-aging preparations for years, often under a trade name tied to Pickart's originally patented complex. This popularity stems from a combination rare in this category: real, if moderate, research support for topical use plus a low risk profile when applied to skin compared with more aggressive active cosmetic ingredients such as retinoids or high-percentage acids.
Who can this actually help? People interested in topical anti-aging skincare with some, though moderate, research support may consider GHK-Cu preparations as an alternative or addition to retinoids and vitamin C, especially if they tolerate those poorly. Anyone considering injectable or systemic GHK-Cu forms promoted in biohacking should be aware that this route of administration today relies almost entirely on extrapolation from animal and cell studies, not human clinical evidence.
History of use
GHK was first isolated from human plasma in 1973 by biochemist Loren Pickart, who observed that albumin from younger donors stimulated liver cell growth in culture more effectively than albumin from older donors — an effect traced to the copper tripeptide bound to it. Over the following decades, from the 1980s through the 2000s, research shifted toward cosmetic uses and chronic wound healing, yielding clinical trials on diabetic ulcers (Mulder et al., 1994) and post-laser-resurfaced skin (Miller et al., 2006). From the 2000s on, GHK-Cu became a popular ingredient in consumer anti-aging cosmetics, and over the last decade — alongside the rising popularity of peptide biohacking — it began to be promoted in injectable and systemic form too, without a corresponding new wave of human research.
Mechanism of action
GHK-Cu acts through several overlapping molecular mechanisms, the best described of which concerns modulation of extracellular matrix metalloproteinases (MMPs) and their natural inhibitors (TIMPs). Metalloproteinases are enzymes that break down old, damaged collagen and elastin fibers in the skin — a process essential for proper tissue remodeling, but overactive in aging and chronically sun-damaged skin. By influencing expression of the genes encoding MMPs and TIMPs, GHK-Cu helps restore the balance between extracellular matrix breakdown and rebuilding, which in in vitro studies on dermal fibroblasts translated into increased collagen and elastin production even at very low, nanomolar peptide concentrations.
A second important mechanism concerns copper's role as an enzymatic cofactor. The Cu2+ ion bound in the GHK-Cu complex is delivered to cells in a bioavailable form and can support the activity of copper-dependent enzymes, including lysyl oxidase — an enzyme essential for forming cross-links between collagen and elastin fibers, which determines the mechanical strength and elasticity of connective tissue. The peptide also shows chemotactic and angiogenic activity in animal models — attracting immune cells and fibroblasts to the site of injury and stimulating new blood vessel formation, which speeds delivery of nutrients and repair cells to healing wounds.
A third, newer area of research concerns GHK-Cu's antioxidant and cytoprotective action independent of collagen synthesis itself — the Pickart and Margolina review describes its effect on genes related to oxidative stress response, DNA repair, and proteasomal system function removing damaged proteins from the cell. This is mechanistically interesting, but it's worth remembering that most of these specific molecular pathways were mapped using bioinformatic methods (gene expression analysis, Connectivity Map) and cell cultures, not confirmed in clinical trials assessing real clinical effect in humans for these specific indications.
The route of administration matters critically. In topical application, GHK-Cu acts locally on skin cells it has physical access to after penetrating the stratum corneum — a process whose efficiency varies substantially depending on formulation (plain cream, microneedling, mesotherapy, impregnated dressing). With systemic or injectable administration, the mechanism should theoretically be analogous at the cellular level, but there are practically no human pharmacokinetic studies determining what fraction of injected GHK-Cu actually reaches target tissues in an active, unmetabolized form rather than being rapidly broken down by circulating plasma peptidases.
MMP/TIMP modulation
GHK-Cu influences expression of matrix metalloproteinases and their inhibitors, restoring balance between collagen breakdown and rebuilding in the skin.
Lysyl oxidase cofactor
The delivered copper ion supports the enzyme that forms cross-links between collagen and elastin fibers, increasing tissue strength.
Chemotaxis and angiogenesis
In animal models the peptide attracts repair cells to the site of injury and stimulates new blood vessel formation.
Antioxidant and cytoprotective action
Influences expression of genes related to oxidative stress response and DNA repair — described mainly through bioinformatic methods and cell cultures.
Evidence: early-stage — based on 3 studies in this database.
Benefits
Common myths
MythSince GHK-Cu has good evidence for cosmetic use, injecting it systemically must be just as well studied and effective.
FactThese are two completely different evidence categories. Clinical evidence concerns almost exclusively topical skin application — the injectable and systemic form has no controlled human clinical trials behind it, and its popularity in biohacking has outpaced the evidence by decades.
MythGHK-Cu is completely safe because it's a natural compound of the body.
FactA molecule's natural origin isn't the same as confirmed safety for every form, dose, and route of administration — especially injectable, non-standardized, and systemically unstudied use. Excess body copper, especially in people with copper metabolism disorders, can be harmful.
MythThe higher the GHK-Cu concentration in a cream, the better the effect.
FactIn vitro studies show GHK-Cu is biologically active even at very low, nanomolar concentrations, and excessively high copper doses in a cosmetic formulation could theoretically shift toward pro-oxidant rather than antioxidant action — more isn't automatically better here.
MythGHK-Cu completely replaces retinoids in anti-aging skincare.
FactOne comparative study found topical GHK-Cu gave comparable or slightly better collagen production improvement than retinoic acid in some of the women studied, but that's a single, moderately sized study, not grounds for generally replacing retinoids, which have a far broader and deeper evidence base in dermatology.
MythCosmetic peptides like GHK-Cu penetrate deep into the skin and work identically to injectable administration.
FactPenetration through the stratum corneum is limited and heavily dependent on formulation — delivery efficiency in a cream is completely different from subcutaneous injection, meaning results from topical-form studies cannot be directly extended to expectations for the injectable form.
Forms & variants
GHK-Cu (Copper Peptide) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Topical cream or serum
The form with the best documented evidence profile — several controlled clinical trials on skin and chronic wounds, good tolerability.
Best for: People interested in anti-aging skincare with moderate but real research support
GHK-Cu-impregnated dressing
Used in clinical trials on chronic wounds, including diabetic ulcers — a specific, medical application, not a cosmetic one.
Best for: Clinical context of chronic wound healing, under medical supervision
Injectable/mesotherapy preparation
Promoted in aesthetic medicine clinics and biohacking as a method of deeper peptide delivery to the skin or systemic action — far less supported than the topical form, with no standardization between vendors.
Best for: No clear editorial recommendation — consider only after consulting a dermatologist or aesthetic-medicine physician, aware of limited evidence
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Available controlled clinical trials, though small, point to a real improvement in skin density, elasticity, and collagen production after 8–12 weeks of regular topical use, comparable to or in some measures slightly better than vitamin C or retinoic acid. This is a stronger evidence basis than for most other "regenerative peptides" discussed in biohacking, though still based on a relatively small number of trials.
There's no good answer, because practically no controlled clinical trials exist assessing the safety of injectable or systemic GHK-Cu administration in humans. Available mechanistic data comes mainly from animal studies and cell cultures, which isn't a sufficient basis for assessing long-term safety of the injected form.
One comparative study showed competitive results, but retinoids have a far broader and deeper evidence base in dermatology spanning decades of clinical trials across many indications. A more reasonable approach is treating GHK-Cu as an alternative when retinoids are poorly tolerated, or as an addition, not a full replacement.
No — GHK-Cu is a specific tripeptide-copper complex with its own described cell-signaling mechanism, different from simply raising the body's copper level through oral supplementation. There's no evidence that oral copper produces the same skin effects as topically applied GHK-Cu complex.
Mainly because its cosmetic/topical use made it into rigorous clinical trials (including a randomized, placebo-controlled trial in diabetic ulcer patients), while BPC-157 and TB-500 remain almost entirely in preclinical research. That difference, however, applies specifically to the topical form — GHK-Cu's injectable form has evidence comparably weak to those two peptides.
They should not use systemic/injectable forms without medical supervision — Wilson's disease is a copper metabolism disorder, and introducing additional copper compounds into the body in this patient group is absolutely contraindicated without consulting the treating physician.
Dosage & timing
Typical dose
Cosmetic form: per manufacturer instructions, usually 1–2 times daily on cleansed skin, at concentrations tested clinically around a few percent of the GHK-Cu complex. Injectable/systemic form: no approved, clinically evidence-based dosing guidelines exist for humans.
Form
Cream, serum, or impregnated dressing for topical use — the form with the best-documented safety and effectiveness profile
Dosing information reflects ranges reported in cited studies and online use for informational purposes only — it does not replace consultation with a doctor or pharmacist.
Best times to take it
- Topical form: usually in the evening, on cleansed skin, as part of a skincare routine — similar to other cosmetic peptides
- No studied, verified timing schedules exist for injectable forms in humans
What to combine with
Use caution with
Zinc — With chronic high-dose systemic supplementation, both minerals compete for the same absorption transporters
Safety
Side effects & contraindications
Possible side effects
With topical application: rarely, local skin irritation or an allergic reaction to formulation ingredients (not always the peptide itself)
With injectable/systemic use: no systematically collected human adverse-effect data — virtually all information comes from anecdotal reports
Theoretical risk of excessive, uncontrolled angiogenesis with high-dose systemic administration, derived from the mechanism of action rather than clinical observation
Risk of local and systemic infection from self-injecting a product of unknown purity, sterility, and actual content
Excess body copper with chronic, high-dose systemic use — a theoretical risk that has not been systematically studied for this specific route of administration
No data whatsoever on long-term safety of injectable use in humans
Contraindications
Wilson's disease and other copper metabolism disorders — an absolute contraindication to systemic copper compound administration without medical supervision
History of cancer or elevated oncological risk — due to the theoretical risk of excessive angiogenesis with systemic forms
Pregnancy and breastfeeding — no safety data for injectable forms; topical cosmetic use is considered relatively low-risk, but consulting a doctor is advisable
Known allergy to a specific formulation's ingredients
Interactions
High-dose zinc supplements — zinc and copper compete for the same absorption transporters, which with chronic systemic supplementation can disturb both minerals' balance
Other topical active cosmetic ingredients (retinoids, high-percentage acids) — no documented harmful interactions, but combining many active substances raises irritation risk
Combining with other unapproved injectable peptides (e.g. BPC-157, TB-500) in biohacking protocols — without any human interaction studies
Is it worth taking?
Who it's for
- People interested in anti-aging skincare looking for an alternative to retinoids when they tolerate those poorly
- People wanting to combine topical GHK-Cu with other, better-studied ingredients (vitamin C, niacinamide) in a skincare routine
- Patients with chronic, slow-healing wounds — only within supervised medical care, not self-experimentation
- Anyone considering injectable/systemic forms should be aware this route of administration relies today almost entirely on extrapolation from animal studies
Not for
- Wilson's disease and other copper metabolism disorders — an absolute contraindication to systemic copper compound administration without medical supervision
- History of cancer or elevated oncological risk — due to the theoretical risk of excessive angiogenesis with systemic forms
- Pregnancy and breastfeeding — no safety data for injectable forms; topical cosmetic use is considered relatively low-risk, but consulting a doctor is advisable
- Known allergy to a specific formulation's ingredients
Evidence
Worth knowing
GHK-Cu plasma concentration declines with age — from ~200 ng/ml at age 20 to ~80 ng/ml at age 60.
A randomized clinical trial in patients with diabetic foot ulcers found three-times-faster wound closure with GHK-Cu gel than with standard care.
GHK-Cu influences expression of over four thousand human genes, described using transcriptome-analysis methods (Connectivity Map).
The injectable/systemic form of GHK-Cu has not a single published controlled human clinical trial behind it.
Studies
GHK-Cu applied to thigh skin for 12 weeks improved collagen production in 70% of treated women, compared with 50% treated with vitamin C cream and 40% with retinoic acid.
Pickart L, Margolina A, International Journal of Molecular Sciences, 2018
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Moderate evidencePickart L, Margolina A · International Journal of Molecular Sciences · 2018
A review summarizing GHK-Cu's mechanisms of action in light of gene-expression analyses (Connectivity Map), covering effects on over four thousand human genes linked to collagen synthesis, metalloproteinases, antioxidant response, and DNA repair. Cites an earlier clinical trial in which 12 weeks of GHK-Cu applied to thigh skin increased collagen production in 70% of women, versus 50% in the vitamin C group and 40% in the retinoic acid group.
View studyEnhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper
Moderate evidenceMulder GD et al. · Wound Repair and Regeneration · 1994
A multicenter, randomized, evaluator-blinded, placebo-controlled clinical trial in patients with diabetic neuropathic foot ulcers. GHK-Cu gel significantly increased the median surface area closure of plantar ulcers (98.5% versus 60.8% for placebo; p<0.05) and tripled the rate of healing versus standard care, with significantly lower infection rates in ulcers treated with the gel (7% versus 34%; p<0.05).
View studyEffects of Topical Copper Tripeptide Complex on CO2 Laser–Resurfaced Skin
Early-stage evidenceMiller TR, Wagner JD, Baack BR, Eisbach KJ · Archives of Facial Plastic Surgery · 2006
A study of 13 patients after CO2 laser resurfacing assessing a topical copper tripeptide complex. No statistically significant difference was found between groups in how quickly erythema resolved, but a patient questionnaire showed a significant difference in subjective post-treatment improvement in overall skin quality favoring the GHK-Cu group (p=0.04) — an example of a modest but honestly reported mixed result.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
196 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
268 publications on this site
Related entries
3.9TB-500
TB-500 circulates online as a "synthetic fragment of thymosin beta-4" supposedly speeding up healing of tendons, ligaments, and muscle — in practice, a marketing name for a poorly defined substance with not a single published human clinical trial behind it.
4.3Collagen
Collagen peptides are often used as a supportive measure for skin elasticity and joint comfort — the evidence is promising but still limited.
2.8Melanotan II
Melanotan II is an unapproved, injectable peptide promoted for "sunless tanning" through direct melanocyte stimulation — a substance with documented, serious adverse effects (from priapism to melanoma cases), banned or flagged by health agencies in multiple countries. This entry is deliberately written with an emphasis on risk, because the evidence of real harm here is far more solid than the evidence for any safe use.
4.2At-Home Dermarolling and Microneedling
Micro-puncturing the skin with a roller covered in hundreds of microneedles — controlled, tiny injuries that trigger a healing response and collagen production. The procedure has solid support in the dermatology literature, above all for acne scarring, but performed at home it carries real, context-specific risks that simply don't exist in a dermatologist's office.
4.4Heart Rate Variability (HRV)
The variability in the time between successive heartbeats is one of the best non-invasive indicators of autonomic nervous system balance — today available in nearly every sports watch.
4.2What is biohacking
From the DIY-biology movement through the Quantified Self to today's social-media-popular trend — what biohacking actually is in practice, and where science ends and marketing begins.
Related articles
PoradnikiBPC-157: What Is Actually Known About the "Regenerative Peptide" — and What Isn't
BPC-157 is often described online as a near-miraculous peptide for tendon, ligament, and joint injuries — regenerating tissue where other methods fail. The problem is that almost this entire reputation rests on rodent studies. Clinical data in humans is extremely limited, the substance isn't approved by any drug agency, and in many countries it's sold in a legal gray area as a "research compound" rather than a drug or supplement. This article is deliberately skeptical — because the evidence that actually exists deserves skepticism.
September 4, 2026
PoradnikiPeptide Therapy: Overview and Safety — What's a Drug, and What's a Gray Market
"Peptides" has become a catch-all buzzword in biohacking covering both real, FDA-approved drugs and hundreds of substances sold online as "research use only" — with no oversight of quality, sterility, or dosing. This article pulls the two apart: we check which peptides actually made it through drug approval, which are circulating in a legal gray zone, and what real risk comes with the second group.
September 16, 2026
PoradnikiWhich Collagen Should You Choose? Type I, II and III — What the Research Actually Says
Collagen is one of the most commonly bought supplements in Poland, yet few people know that 'collagen' isn't a single substance — it's a family of proteins with different uses. We explain the difference and help you pick the right type.
August 18, 2026
PoradnikiCollagen and Skin Health: What Do Two Meta-Analyses Show?
Collagen powder or capsules are one of the fastest-growing segments of the beauty supplement market — and, rare for this category, one of the few where the popular promise ("firmer, better-hydrated skin") has earned solid confirmation in two independent, well-designed meta-analyses. This is a rare situation in supplement science, worth a closer look precisely because the evidence here is unusually consistent.
August 25, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.